Neck management in medullary thyroid carcinoma

被引:20
|
作者
Oskam, I. M. [1 ]
Hoebers, F. [2 ]
Balm, A. J. M. [1 ]
van Coevorden, F. [3 ]
Bais, E. M. [4 ]
Hart, A. M. [2 ]
van den Brekel, M. W. M. [1 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, NL-1066 CX Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, NL-1066 CX Amsterdam, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, NL-1066 CX Amsterdam, Netherlands
[4] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, NL-1066 CX Amsterdam, Netherlands
来源
EJSO | 2008年 / 34卷 / 01期
关键词
elective neck dissection; lymph node metastases; locoregional control; medullary thyroid cancer;
D O I
10.1016/j.ejso.2007.03.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The aims of this study were to retrospectively evaluate incidence and patterns of lymph node metastases, surgical treatment and prognostic factors of medullary thyroid carcinoma. Methods: Out of a group of 70 MTC patients data of 67 patients were collected. Sixty-two of these patients underwent surgery. Apart from thyroidectomy, 16 patients underwent a bilateral neck dissection, 21 a unilateral neck dissection and 29 a paratracheal dissection or node-picking operation. Thirty-six patients were irradiated, of which 31 postoperatively and five with palliative intent. Results: Lymph node metastases were found in 91% of the ipsilateral neck dissection specimens, 91% of the paratracheal dissections and 63% of the contralateral dissections. Of the 12 elective neck dissections, 5 were tumor positive. Level VI was positive in 91% of the cases where a dissection was done, whereas preoperatively only 16% were scored tumor positive. During follow-up 22 of the 67 patients developed one or more locoregional recurrences (in total 28 recurrences). The most important factors that were correlated with a worse prognosis of survival were late stage of disease (stage III and IV) (p = 0.0014), high number of positive lymph nodes (p = 0.0023) and incomplete surgical resection (p = 0.0002). Conclusions: The high rate of locoregional recurrences in this study are a strong argument for a more aggressive approach to the primary and neck. A routine central and ipsilateral selective neck dissection of levels II-V should be considered in all MTC patients based on the high incidence of metastases and the relative low morbidity of a unilateral neck dissection. Patients referred after thyroidectomy alone with elevated (stimulated) calcitonin levels should be re-operated, performing an elective or therapeutic central and unilateral neck dissection. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 50 条
  • [1] Management of medullary thyroid carcinoma
    Subramanian, S.
    Brzhezovskiy, V.
    Lyubaev, V.
    Kochurina, G.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 299 - 299
  • [2] MANAGEMENT OF MEDULLARY CARCINOMA OF THE THYROID
    SIMPSON, WJ
    PALMER, JA
    ROSEN, IB
    MUSTARD, RA
    [J]. AMERICAN JOURNAL OF SURGERY, 1982, 144 (04): : 420 - 422
  • [3] Management of medullary thyroid carcinoma
    Jimenez, Camilo
    Hu, Mim I-Nan
    Gagel, Robert F.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (02) : 481 - +
  • [4] Thyroid medullary carcinoma occurring laterally in the neck
    Harach, HR
    Williams, ED
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03): : 983 - 984
  • [5] Management of hereditary medullary thyroid carcinoma
    Pappa, Theodora
    Alevizaki, Maria
    [J]. ENDOCRINE, 2016, 53 (01) : 7 - 17
  • [6] Management of hereditary medullary thyroid carcinoma
    Moley, JF
    Wells, SA
    [J]. FAMILIAL CANCER AND PREVENTION: MOLECULAR EPIDEMIOLOGY - A NEW STRATEGY TOWARD CANCER CONTROL, 1999, : 377 - 384
  • [7] Diagnosis and management of medullary thyroid carcinoma
    Massoll, N
    Mazzaferri, EL
    [J]. CLINICS IN LABORATORY MEDICINE, 2004, 24 (01) : 49 - +
  • [8] Medullary thyroid carcinoma: Therapy and management
    Hashizume, K
    [J]. INTERNAL MEDICINE, 1999, 38 (01) : 3 - 3
  • [9] Management of hereditary medullary thyroid carcinoma
    Theodora Pappa
    Maria Alevizaki
    [J]. Endocrine, 2016, 53 : 7 - 17
  • [10] Management of medullary carcinoma of the thyroid: a review
    Jayasinghe, Ravindri
    Basnayake, Oshan
    Jayarajah, Umesh
    Seneviratne, Sanjeewa
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (07)